Quest Diagnostics CapEx decreased by 27.8% to $114.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $117.00M to $114.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 6.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.00M | $89.00M | $144.00M | $63.00M | $76.00M | $118.00M | $147.00M | $127.00M | $104.00M | $105.00M | $72.00M | $104.00M | $92.00M | $106.00M | $123.00M | $117.00M | $108.00M | $144.00M | $158.00M | $114.00M |
| QoQ Change | — | +6.0% | +61.8% | -56.3% | +20.6% | +55.3% | +24.6% | -13.6% | -18.1% | +1.0% | -31.4% | +44.4% | -11.5% | +15.2% | +16.0% | -4.9% | -7.7% | +33.3% | +9.7% | -27.8% |
| YoY Change | — | — | — | — | -9.5% | +32.6% | +2.1% | +101.6% | +36.8% | -11.0% | -51.0% | -18.1% | -11.5% | +1.0% | +70.8% | +12.5% | +17.4% | +35.8% | +28.5% | -2.6% |